Spots Global Cancer Trial Database for GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer
Official Title: Open Label Study of the Effect of GTx-758 on Serum PSA and Free Testosterone Levels in Men With Castration Resistant Prostate Cancer and Maintained on Androgen Deprivation Therapy
Study ID: NCT01420861
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to assess the effect of GTx-758 on Serum Prostate-specific antigen (PSA) levels in men with castrate resistant prostate cancer who are maintained on androgen deprivation therapy (Serum PSA response and Serum PSA progression)
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
GTx Investigative Site, San Bernardino, California, United States
GTx Investigational Site, Jeffersonville, Indiana, United States
GTx Investigative Site, Albuquerque, New Mexico, United States
GTx Investigative Site, Syracuse, New York, United States
GTx Investigative Site, Bala-Cynwyd, Pennsylvania, United States
GTx Investigative Site, San Antonio, Texas, United States
GTx Investigative Site, Virginia Beach, Virginia, United States
Contact Details
Name: Mitchell Steiner, MD
Affiliation: GTx
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
